Topics

Companies Related to "Proviral DNA as a Target for HIV-1 Resistance Analysis" [Most Relevant Company Matches] RSS

23:59 EST 21st November 2019 | BioPortfolio

Here are the most relevant search results for "Proviral DNA as a Target for HIV-1 Resistance Analysis" found in our extensive corporate database of over 50,000 company records.

Showing "Proviral Target Resistance Analysis" Companies 1–25 of 2,300+

Relevant

Target Health Inc. & LifeOnKey Inc.

Target Health, (www.targethealth.com) established in 1993, is a full service eCRO with full-time staff dedicated to all aspects of drug and device development. Areas of expertise include Regulatory Affairs, strategic planning, IND, IDE, eCTD NDA, PMA and 510(k) submissions, Clinical Trial Monitoring and Project Management, Biostatistics, Data Management, E...


Paratek Pharmaceuticals Incorporated

Paratek's mission is to overcome the major worldwide problem of bacterial resistance through the application of new proprietary technology and through the development of new antibiotics. Paratek has established two product development programs to identify and develop new pharmaceuticals for the treatment of infectious diseases:The Tetracycline Resistance Project ("Tet Project") based on expertise ...

Novexel

Novexel is a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The ever increasing resistance to marketed antibiotics has led to a clear need for


Target Corp.

Minneapolis-based Target Corporation (NYSE:TGT) serves guests at 1,764 stores across the United States and at Target.com. The company plans to open its first stores in Canada in 2013. In addition, the company operates a credit card segment that offers branded proprietary credit card products. Since 1946, Target has given 5 percent of its income through com...

Sequenom

SEQUENOM is committed to providing the best genetic analysis products that translate genomic science into superior solutions for biomedical research, agricultural applications, molecular medicine and non-invasive prenatal diagnostics research, and potentially, clinical utility. The Company's proprietary MassARRAY® system is a high-performance DNA analysis platform that efficiently and precisely...

PLANTON GmbH

Infectious diseases are the most frequent causes of death. Microbial resistance to antibiotics is an increasing problem in medical treatment and thus an important focus in pharmaceutical research. PLANTON develops and produces a novel class of antiinfectiva – antimicrobial peptides. These molecules have a strong antibiotic efficacy and a special mechanism avoiding resistance of human pathogens. ...

Target Corporation

Minneapolis-based Target Corporation (NYSE: TGT) serves guests at 1,699 stores in 49 states nationwide and at Target.com. Target is committed to providing a fun and convenient shopping experience with access to unique and highly differentiated products at affordable prices. Since 1946, the corporation has given 5 percent of its income through community grants and programs like Take Charge of Educa...

Virco Lab, Inc.

Virco BVBA is a world leader in the field of HIV resistance testing services for clinical practice and clinical studies, advancing research that correlates laboratory testing with clinical management, while offering a wide range of HIV resistance diagnostics. (Virco Lab, Inc. is the US operating division of Virco.) The company applies the latest technologies in molecular biology, medical virology,...

Target BioScience AG

Target BioScience AG is a consulting firm focused exclusively on the pharmaceutical and biotechnology fields. Our trademark is our highly practical approach. Target BioScience AG was originally founded by Dr. Meinrad Good in 1993 as the pharmaceutical and biotech consulting company "BPB". In 2000, the company was re-established as "Target BioScience AG" in response to growth in international opera...

Protein Structure Factory

The term "Protein Structure Factory" stands for a common initiative of structural biologists from the Berlin area and the German Human Genome Project (DHGP). The Protein Structure Factory represents an integrative approach to the high-throughput analysis of three-dimensional protein structures.We have set out to establish an analytical infrastructure to characterize human proteins whose cDNA seque...

Memgen, LLC

Memgen is a clinical-stage biotechnology company developing immunotherapies to improve survival and quality of life of patients with cancer, autoimmune conditions and infectious diseases. Memgen’s patent-protected, re-engineered molecules, which are based on the tumor necrosis factor (TNF) superfamily of molecules, target specific receptors express...

D-TARGET SA

Stratigically located in Switzerland, the heart of Europe, D-TARGET is the number one clinical research organisation specializing in Clinical and Regulatory Services throughout the European continent. Medical device manufacturers worldwide rely upon D-TARGET's highly trained, multi-lingual professionals for result-oriented solutions in bringing their products to life in more than 25 European count...

Mobidiag Ltd.

Mobidiag is a commercial stage, fast growing molecular diagnostics company whose affordable, widely applicable and robust technology makes the power of molecular diagnostics available to address the spread of antimicrobial resistance (AMR) by rapid detection of pathogens and their potential resistance to antibiotics. Through its Amplidiag® and Novodiag...

Target ALS Foundation

Target ALS is an independent, non-profit, and privately funded consortium of researchers from academic and biotech/pharma laboratories entirely focused on finding a treatment for patients living with ALS. The organization funds 19 preformed research consortia involving investigators across 30 academic institutions. Target ALS also funds Springboard Fellows...

Pharmaceutica Limited

Pharmaceutica Limited is a privately owned pharmaceutical company founded in March 2003, to discover and develop a new generation of anti-infective drug technologies that combat the increasing problem caused by the rapid evolution of resistance by pathogenic organisms. The company is targeting both human and veterinary applications for its technologies.The initial focus is to find a solution to th...

Probably Relevant

Mpex Pharmaceuticals, Inc.

Mpex Pharmaceuticals is a clinical stage biopharmaceutical company whose mission is to develop important new therapies to combat the growing issue of antibiotic resistance. The company's internal development pipeline focuses on combining proprietary formulations, PK/PD strategies and novel potentiating agents with proven antibiotics to overcome or directly inhibit the molecular mechanisms in bacte...

AB BIODISK

The AB BIODISK name, company spirit and reputation are based on commitment to the highest standards of science. The company is perhaps best known for its dedication to antimicrobial resistance testing since the early 1950s. The mission left by its scientific founder, Hans Ericsson, Professor of Microbiology at the Karolinska Institute, “to Promote the Rational Use of Antibiotics” has been fait...

The Brain Resource Company - Netherlands

The Brain Resource Company (BRC) is focussed on commercialising brain function analysis. The BRC can provide objective reports about brain function based on psychophysiological (EEG, ERP, ECG, EDA, EMG etc.) and neuropsychological (attention, memory, etc.) data - and - if required fMRI. Data are collected using a standardized, 'quality controlled' assessments. Data are analysed at the Central Anal...

LUDESI

Ludesi is a software company with the business concept to offer quality-controlled 2D gel image analysis using technically advanced in-house software. The image analysis is offered to customers on a pay-per-image basis allowing scientists worldwide to get valid and reliable analysis results without paying expensive software license costs.By using a specialized analysis center with professionals pe...

BioAlliance Pharma

BioAlliance Pharma (Euronext Paris: BIO) is an emerging specialty pharmaceutical company focused on the development of innovative therapeutics targeting drug resistance in cancer, HIV, and severe and opportunistic infections.To attack the challenge of resistance, the company has multiple product opportunities in two broad proprietary drug delivery systems represented by the Lauriad® adhesive tech...

Target Health Incorporated

TARGET HEALTH INC. is a full service CRO with staff dedicated to all aspects of Regulatory Affairs, Clinical Research, Biostatistics, Data Management, Strategic Planning and Drug and Device Development. TARGET HEALTH also has a group of specialized advisors in the areas of Toxicology, Analytical Methods Validation, Product and Process Development, Quality Assurance, Manufacturing and Animal Health...

Discuva

Discuva aims to revolutionise the treatment of disease caused by bacterial infection by discovering and developing new antibiotics against highly drug-resistant pathogens. The company’s innovative proprietary technologies both identify new small molecule drugs against novel bacterial targets and facilitate their progression through to drug candidates ...

Genetic Analysis AS

Genetic Analysis has developed and launched the first gene-based routine test for the mapping and diagnosis of diseases related to dysbiosis and imbalances in the digestive system. The company markets the GA-map™ technology to three market segments: commercial routine testing, pharma companies and the research market. Genetic Analysis was established ...

Vividion Therapeutics, Inc.

Conventional drug discovery is target-centric; a compound library is screened using a target-specific assay and high-affinity binding ligands are optimized to develop a drug candidate. This approach is limited, as research is performed in artificial systems that fail to account for native protein structure, context and function. Further, conventional targe...

ORIC Pharmaceuticals

ORIC Pharmaceuticals is a privately held, clinical-stage oncology company focused on making cancer treatments more effective by addressing mechanisms of resistance. ORIC’s lead program, ORIC-101, is a potent and selective small molecule antagonist of the glucocorticoid receptor, which has been linked to treatment resistance to multiple classes of anti...


More From BioPortfolio on "Proviral DNA as a Target for HIV-1 Resistance Analysis"

Quick Search

Corporate Database Quicklinks